Individualizing Immune Modulation & Chemotherapy

The i2mc research group is located at the Department of Medical Biochemistry, Rikshospitalet University Hospital. In focus of the research of this group is the individualization of immunosuppressive treatment and chemotherapy. By the combination of pharmacokinetics, pharmacodynamics and pharmacogenomics, sources for individual variability in the response of specific drugs are investigated.

Visit our main web pages at IMUP

Members of the group

Recent publications (PubMed)